{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T07:45:40Z","timestamp":1789544740395,"version":"build-2803163510"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,5]]},"DOI":"10.7759\/cureus.35783","type":"journal-article","created":{"date-parts":[[2023,3,5]],"date-time":"2023-03-05T14:20:22Z","timestamp":1678026022000},"source":"Crossref","is-referenced-by-count":5,"title":["Treatment Outcomes and Survival in Hypercalcemia of Malignancy: A Grave Metabolic Emergency"],"prefix":"10.7759","author":[{"given":"Sweety","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aviral","family":"Rastogi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pragya","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atokali","family":"Chophy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Roushan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay S","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepa","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bela","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1980.01380060012004","article-title":"Incidence of hypercalcemia and malignant neoplasm","volume":"115","author":"Burt ME","year":"1980","unstructured":"Burt ME, Brennan MF. Incidence of hypercalcemia and malignant neoplasm. Arch Surg. 1980, 115:704-7. 10.1001\/archsurg.1980.01380060012004","journal-title":"Arch Surg"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp042806","article-title":"Clinical practice. Hypercalcemia associated with cancer","volume":"352","author":"Stewart AF","year":"2005","unstructured":"Stewart AF. Clinical practice. Hypercalcemia associated with cancer. N Engl J Med. 2005, 352:373-9. 10.1056\/NEJMcp042806","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.749","article-title":"Prevalence of hypercalcemia among cancer patients in the United States","volume":"5","author":"Gastanaga VM","year":"2016","unstructured":"Gastanaga VM, Schwartzberg LS, Jain RK, et al.. Prevalence of hypercalcemia among cancer patients in the United States. Cancer Med. 2016, 5:2091-100. 10.1002\/cam4.749","journal-title":"Cancer Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3810\/pgm.2004.04.1486","article-title":"Understanding hypercalcemia. Its metabolic basis, signs, and symptoms","volume":"115","author":"Inzucchi SE","year":"2004","unstructured":"Inzucchi SE. Understanding hypercalcemia. Its metabolic basis, signs, and symptoms. Postgrad Med. 2004, 115:69-76. 10.3810\/pgm.2004.04.1486","journal-title":"Postgrad Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2004.04.006","article-title":"Electrocardiographic manifestations: electrolyte abnormalities","volume":"27","author":"Diercks DB","year":"2004","unstructured":"Diercks DB, Shumaik GM, Harrigan RA, Brady WJ, Chan TC. Electrocardiographic manifestations: electrolyte abnormalities. J Emerg Med. 2004, 27:153-60. 10.1016\/j.jemermed.2004.04.006","journal-title":"J Emerg Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1986.tb02795.x","article-title":"Malignant hypercalcemia\u2014a hospital survey","volume":"220","author":"Blomqvist CP","year":"1986","unstructured":"Blomqvist CP. Malignant hypercalcemia\u2014a hospital survey. Acta Med Scand. 1986, 220:455-63. 10.1111\/j.0954-6820.1986.tb02795.x","journal-title":"Acta Med Scand"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2014.433","article-title":"The risk of cancer in primary care patients with hypercalcaemia: a cohort study using electronic records","volume":"111","author":"Hamilton F","year":"2014","unstructured":"Hamilton F, Carroll R, Hamilton W, Salisbury C. The risk of cancer in primary care patients with hypercalcaemia: a cohort study using electronic records. Br J Cancer. 2014, 111:1410-2. 10.1038\/bjc.2014.433","journal-title":"Br J Cancer"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/9781118453926.ch70","article-title":"Non-parathyroid hypercalcemia","author":"Horwitz MJ","year":"2013","unstructured":"Horwitz MJ, Hodak SP, Stewart AF. Non-parathyroid hypercalcemia. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Rosen CJ (ed): Wiley, New York, NY; 2013. 10.1002\/9781118453926.ch70"},{"key":"ref9","article-title":"Hypercalcemia in glioblastoma multiforme","volume":"27","author":"Seif FE","year":"2006","unstructured":"Seif FE, Azar S, Barake M, Sawaya R. Hypercalcemia in glioblastoma multiforme. Neuro Endocrinol Lett. 2006, 27:547-8.","journal-title":"Neuro Endocrinol Lett"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.emc.2018.04.008","article-title":"Rapid fire: hypercalcemia","volume":"36","author":"Carrick AI","year":"2018","unstructured":"Carrick AI, Costner HB. Rapid fire: hypercalcemia. Emerg Med Clin North Am. 2018, 36:549-55. 10.1016\/j.emc.2018.04.008","journal-title":"Emerg Med Clin North Am"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1241821","article-title":"Hypercalcemia in cancer patients: pathobiology and management","volume":"42","author":"Santarpia L","year":"2010","unstructured":"Santarpia L, Koch CA, Sarlis NJ. Hypercalcemia in cancer patients: pathobiology and management. Horm Metab Res. 2010, 42:153-64. 10.1055\/s-0029-1241821","journal-title":"Horm Metab Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2014.07.005","article-title":"Denosumab for the management of hypercalcemia of malignancy in patients with multiple myeloma and renal dysfunction","volume":"14","author":"Cicci JD","year":"2014","unstructured":"Cicci JD, Buie L, Bates J, van Deventer H. Denosumab for the management of hypercalcemia of malignancy in patients with multiple myeloma and renal dysfunction. Clin Lymphoma Myeloma Leuk. 2014, 14:e207-11. 10.1016\/j.clml.2014.07.005","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2011.562196","article-title":"Clinical utilization of cinacalcet in hypercalcemic conditions","volume":"7","author":"Messa P","year":"2011","unstructured":"Messa P, Alfieri C, Brezzi B. Clinical utilization of cinacalcet in hypercalcemic conditions. Expert Opin Drug Metab Toxicol. 2011, 7:517-28. 10.1517\/17425255.2011.562196","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.2.558","article-title":"Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials","volume":"19","author":"Major P","year":"2001","unstructured":"Major P, Lortholary A, Hon J, et al.. Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials. J Clin Oncol. 2001, 19:558-67. 10.1200\/JCO.2001.19.2.558","journal-title":"J Clin Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-112-7-499","article-title":"Cancer-associated hypercalcemia: morbidity and mortality. Clinical experience in 126 treated patients","volume":"112","author":"Ralston SH","year":"1990","unstructured":"Ralston SH, Gallacher SJ, Patel U, Campbell J, Boyle IT. Cancer-associated hypercalcemia: morbidity and mortality. Clinical experience in 126 treated patients. Ann Intern Med. 1990, 112:499-504. 10.7326\/0003-4819-112-7-499","journal-title":"Ann Intern Med"},{"key":"ref16","article-title":"Hypercalcaemia--a hospital survey","volume":"49","author":"Fisken RA","year":"1980","unstructured":"Fisken RA, Heath DA, Bold AM. Hypercalcaemia--a hospital survey. Q J Med. 1980, 49:405-18.","journal-title":"Q J Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19930215)71:4<1309::aid-cncr2820710423>3.0.co;2-m","article-title":"Incidence of hypercalcemia in patients with malignancy referred to a comprehensive cancer center","volume":"71","author":"Vassilopoulou-Sellin R","year":"1993","unstructured":"Vassilopoulou-Sellin R, Newman BM, Taylor SH, Guinee VF. Incidence of hypercalcemia in patients with malignancy referred to a comprehensive cancer center. Cancer. 1993, 71:1309-12. 10.1002\/1097-0142(19930215)71:4&lt;1309::aid-cncr2820710423&gt;3.0.co;2-m","journal-title":"Cancer"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-4250","article-title":"PTHrP-mediated hypercalcemia: causes and survival in 138 patients","volume":"100","author":"Donovan PJ","year":"2015","unstructured":"Donovan PJ, Achong N, Griffin K, Galligan J, Pretorius CJ, McLeod DS. PTHrP-mediated hypercalcemia: causes and survival in 138 patients. J Clin Endocrinol Metab. 2015, 100:2024-9. 10.1210\/jc.2014-4250","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/142542-treatment-outcomes-and-survival-in-hypercalcemia-of-malignancy-a-grave-metabolic-emergency","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:51:22Z","timestamp":1707508282000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/142542-treatment-outcomes-and-survival-in-hypercalcemia-of-malignancy-a-grave-metabolic-emergency"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,5]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.35783","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,5]]}}}